Project Manager, Cell Therapy Platform at Orca Bio

Sacramento, California, United States

Orca Bio Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Cell TherapyIndustries

Requirements

  • 4+ years of experience working in a software development organization, biotech, pharma, healthcare operations, digital health, consulting, or supply chain
  • Bachelor’s degree
  • Strong analytical skills
  • Project or program management experience
  • Ability to translate between business needs and technical execution
  • Excellent communication skills

Responsibilities

  • Serve as the business lead for the design, development, and implementation of Orca Bio’s digital ordering and coordination platform supporting the commercial launch of Orca-T
  • Partner closely with the technical team to convey functional requirements, manage development priorities, oversee project timelines, ensure quality, and coordinate platform deployment
  • Oversee and manage the project budget to ensure alignment with business objectives and resource efficiency
  • Ensure the order management workflow and patient journey are accurately captured and integrated into the platform, with a focus on meeting key customer needs
  • Provide input on platform scalability, functionality, and system interfaces, informed by business and customer feedback
  • Serve as the key liaison across internal functions (e.g., commercial, medical, logistics, manufacturing) to gather and align cross-functional requirements, ensuring accurate development and seamless end-to-end integration
  • Develop and maintain user-facing documentation and training materials to support internal teams and external partners
  • Following platform roll out, lead high-impact projects that improve operational effectiveness and enable scale
  • Partner with manufacturing and supply teams to enhance capacity planning, slot booking, and real-time visibility tools
  • Conduct strategic analyses (e.g., U.S. apheresis market assessment) to inform investment decisions and internal infrastructure build-out
  • Lead cross-functional project teams to design and implement scalable systems, processes, and tools that support commercial readiness
  • Act as a trusted thought partner to Product Supply leadership in identifying and solving operational pain points with long-term impact

Skills

Project Management
Platform Development
Cross-Functional Collaboration
Stakeholder Management
Operational Strategy
Digital Platforms
User Experience
Supply Chain Coordination

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI